Navigation Links
They Call It PMS Because Mad Cow Disease Was Already Taken

Premenstrual syndrome is an endocrine disorder characterized by nervous irritability, abnormal sensation in breasts, abdominal pain, thirst, headache and pelvic congestion.

For the first time, low dose oral contraceptive with a unique progestin and dosing regimen has been found effective in treating symptoms of premenstrual dysphoric disorder// (PMDD), the most severe form of premenstrual syndrome.

PMDD is characterized by cyclical mood, behavioral and physical symptoms that can be debilitating in some women. The cause of PMDD is unknown, although changes in steroid hormone levels have been held responsible for symptom production. On the same basis, hormones can be given to suppress ovarian activity thereby preventing the symptoms in these women.

A multi-center, double-blind, randomized clinical trial was conducted involving 450 women with symptoms of PMDD. The participants were given either the oral contraceptive or a placebo. Women who were given the oral contraceptive had significantly greater improvement (48.4 percent compared to 36.1 percent of women on placebo) in productivity, enjoyment of hobbies, social activities, and interpersonal relationships, and experienced greater symptom reduction. Forty-four women from both groups withdrew from the study due to adverse effects such as nausea and intermenstrual bleeding.

The low dose oral contraceptive contains drospirenone, a new progestin, and ethinyl estradiol. It was administered for 24 days followed by four days of inactive pills. The new regimen was designed for greater ovarian suppression and a more stable hormonal environment. The women were evaluated over the course of two menstrual cycles.

The analysis of the results has proved that the oral contraceptive method is effective in reducing symptoms associated with the PMS. For women who are seeking contraception in addition to control of PMDD, this would be more efficient because they could take just on e treatment.


'"/>




Related medicine news :

1. More Britons Take To Alcohol Because Of Stress
2. Do Women Die In Childbirth Because It Is More Preferable?
3. No Kidding, Children Obese Because of Overeating
4. Your Kids may Not Be Fat Because of too Much TV or Video Games
5. TB Cases, Deaths Decline in Yemen Because of Awareness Programs
6. Number of TB Cases in Malta Increasing in Part Because of Immigration
7. Junior Doctors Facing More Misery Because of Contract Deadlock: BMA
8. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
9. Vitamins-The answer to Heart Disease?
10. Link between Constipation and Parkinsons Disease
11. Levels Of Blood Proteins May Help Heart Disease Care
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are ... for this recognition are considered among the top 2 percent of lawyers practicing within ... of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 ... Tomorrow,s Leaders Scholarship is any indication, the future is ... online at www.diabetesscholars.org by the Diabetes Scholars ... in the way of academic and community service excellence. ... program since 2012, and continues to advocate for people ...
Breaking Medicine Technology: